Why the study?
Left atrial enlargement is a critical marker of target organ damage in essential hypertension, but simple and accessible tools for individualized early screening in routine practice remain limited.
Population
251 hypertensive patients admitted between August 2023 and September 2024
Design
Single-center retrospective cross-sectional study
Key result
A diagnostic nomogram incorporating five clinical variables demonstrated high internal discrimination for identifying left atrial enlargement in essential hypertension, with an AUC of 0.937.
Authors
Loading...
May aid preliminary risk stratification in hypertension; leaves open external validation before clinical use.
Cross-Sectional (n=251)
No
Effect estimate: AUC 0.937 (95% CI 0.899-0.975)
A novel 5-variable clinical nomogram demonstrated high internal discrimination for identifying left atrial enlargement in patients with essential hypertension, offering a simple tool for early risk stratification.
Wen et al. (2026) conducted a cross-sectional in Essential hypertension (n=251). Clinical predictors (age, hypertension duration, atrial fibrillation, hypertension stage, coronary heart disease) was evaluated on Discriminative performance of the nomogram for identifying left atrial enlargement (AUC 0.937, 95% CI 0.899-0.975). A diagnostic nomogram incorporating five clinical variables demonstrated high internal discrimination for identifying left atrial enlargement in essential hypertension, with an AUC of 0.937.